Compare TOWN & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TOWN | CNTA |
|---|---|---|
| Founded | 1998 | 2020 |
| Country | United States | United Kingdom |
| Employees | 1251 | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 3.5B |
| IPO Year | N/A | 2021 |
| Metric | TOWN | CNTA |
|---|---|---|
| Price | $35.43 | $26.78 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 10 |
| Target Price | N/A | ★ $39.50 |
| AVG Volume (30 Days) | 467.5K | ★ 1.1M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 3.08% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $35.63 | N/A |
| Revenue Next Year | $5.18 | N/A |
| P/E Ratio | $16.23 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $29.43 | $9.60 |
| 52 Week High | $37.86 | $30.58 |
| Indicator | TOWN | CNTA |
|---|---|---|
| Relative Strength Index (RSI) | 48.87 | 64.73 |
| Support Level | $34.39 | $21.93 |
| Resistance Level | $37.13 | $30.29 |
| Average True Range (ATR) | 0.95 | 1.13 |
| MACD | -0.21 | 0.29 |
| Stochastic Oscillator | 36.47 | 82.81 |
Towne Bank is a financial services company that places special emphasis on serving the financial needs of individuals, commercial enterprises, and professionals, offering retail and commercial banking services to numerous markets in Virginia and North Carolina. The company has three reportable segments: the Banking Segment provides loan and deposit services to retail and commercial customers and provides commercial mortgage brokerage services and investment and asset management services, and the Realty Segment provides residential real estate services and mortgage loans. It also provides resort property management and residential and commercial title insurance, and the Insurance Segment provides a wide array of insurance products, including property, casualty, life, and health insurance.
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.